Dna X (SONM) Shares Outstanding (Weighted Average) (2018 - 2025)
Dna X filings provide 8 years of Shares Outstanding (Weighted Average) readings, the most recent being $722689.0 for Q4 2025.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 175.71% to $722689.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $722689.0, a 175.71% increase, with the full-year FY2025 number at $722689.0, up 175.71% from a year prior.
- Shares Outstanding (Weighted Average) hit $722689.0 in Q4 2025 for Dna X, down from $984927.0 in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $40.9 million in Q1 2023 to a low of $262118.0 in Q4 2024.
- Median Shares Outstanding (Weighted Average) over the past 5 years was $6.2 million (2021), compared with a mean of $10.1 million.
- Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 93.89% in 2024 and later surged 265.62% in 2025.
- Dna X's Shares Outstanding (Weighted Average) stood at $9.5 million in 2021, then surged by 205.23% to $28.9 million in 2022, then tumbled by 85.16% to $4.3 million in 2023, then tumbled by 93.89% to $262118.0 in 2024, then skyrocketed by 175.71% to $722689.0 in 2025.
- The last three reported values for Shares Outstanding (Weighted Average) were $722689.0 (Q4 2025), $984927.0 (Q3 2025), and $7.7 million (Q2 2025) per Business Quant data.